Evidence map›Paper›PMID 28966666›Full record

ArticleExperimental and therapeutic medicine2017

Identification of potential therapeutic target genes and miRNAs for primary myelofibrosis with microarray analysis.

Yong Liu, Bo Wei, Xuebing Zhang, Dehui Xu, Bo Wang, Guochao Yin, Dawer Gu, Yuxiang Li, Daliang Kong

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Experimental and therapeutic medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Distinct profile of CD34Journal of experimental & clinical cancer research : CR · 2021
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yong LiuDepartment of Orthopaedics, Jilin Oilfield General Hospital, Songyuan, Jilin 131200, P.R. China.
Bo WeiDepartment of Neurosurgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China.
Xuebing ZhangDepartment of Orthopaedics, Jilin Oilfield General Hospital, Songyuan, Jilin 131200, P.R. China.
Dehui XuDepartment of Orthopaedics, Jilin Oilfield General Hospital, Songyuan, Jilin 131200, P.R. China.
Bo WangDepartment of Orthopaedics, Jilin Oilfield General Hospital, Songyuan, Jilin 131200, P.R. China.
Guochao YinDepartment of Orthopaedics, Jilin Oilfield General Hospital, Songyuan, Jilin 131200, P.R. China.
Dawer GuDepartment of Orthopaedics, Jilin Oilfield General Hospital, Songyuan, Jilin 131200, P.R. China.
Yuxiang LiDepartment of Orthopaedics, Jilin Oilfield General Hospital, Songyuan, Jilin 131200, P.R. China.
Daliang KongDepartment of Orthopaedics, China-Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China.
Jilin University · CNUnion Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present study was to identify potential therapeutic target genes and miRNAs for primary myelofibrosis (PMF). The dataset GSE53482 was downloaded from the Gene Expression Omnibus database. The differentially expressed genes (DEGs) and differentially expressed miRNAs (DEMs) of peripheral blood (PB) cluster of differentiation (CD)34

Indexed as

differentially expressed genesdifferentially expressed miRNAsnetworkprimary myelofibrosis

Identifiers

PMID28966666
PMCPMC5615205
OpenAlexW2742329338

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.